High levels of Epstein–Barr virus DNA in latently infected gastric adenocarcinoma
- 10 November 2008
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 89 (1) , 80-90
- https://doi.org/10.1038/labinvest.2008.103
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Laboratory Assays for Epstein-Barr Virus-Related DiseaseThe Journal of Molecular Diagnostics, 2008
- Epstein–Barr virus-associated tumours: an update for the attention of the working pathologistJournal of Clinical Pathology, 2007
- Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs)Blood, 2006
- Gastric Cancer and the High Combination Prevalence of Host Cytokine Genotypes and Helicobacter pylori in HondurasClinical Gastroenterology and Hepatology, 2006
- LMP1 signaling and activation of NF-κB in LMP1 transgenic miceOncogene, 2005
- The future of gastric cancer preventionGastric Cancer, 2004
- Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytesGastric Cancer, 2003
- GI Cancer High Prevalence of Epstein-Barr Virus in Gastric Remnant Carcinoma after Billroth-II ReconstructionScandinavian Journal of Gastroenterology, 2002
- Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCRArchiv für die gesamte Virusforschung, 1997
- Epstein-Barr virus and gastric remnant cancerCancer, 1994